Cargando…

Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors

The effect of metabolic syndrome on chronic liver diseases other than non-alcoholic fatty liver disease has not been fully elucidated. Our goal was to evaluate if metabolic syndrome increased the risk of liver-related complications, specifically hepatocellular carcinoma (HCC) and decompensation, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Alina, Le, An, Lee, Mei-Hsuan, Lin, Yu-Ju, Nguyen, Pauline, Trinh, Sam, Dang, Hansen, Nguyen, Mindie H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940826/ https://www.ncbi.nlm.nih.gov/pubmed/29740031 http://dx.doi.org/10.1038/s41598-018-25533-2

Ejemplares similares

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
por: Hoang, Joseph K., et al.
Publicado: (2016)

Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study
por: Zou, Biyao, et al.
Publicado: (2018)

Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis
por: Tran, Sally Ann, et al.
Publicado: (2018)

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B
por: Wang, Christina, et al.
Publicado: (2016)

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
por: Nguyen, Mindie H., et al.
Publicado: (2022)

Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar
por: Kim, Yoona A., et al.
Publicado: (2017)

Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis
por: Vutien, Philip, et al.
Publicado: (2017)

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience
por: Nguyen, Peter, et al.
Publicado: (2017)

Predictors of hospital re-admissions among Hispanics with hepatitis C-related cirrhosis
por: Atla, Pradeep R., et al.
Publicado: (2016)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis
por: Cheng, Ran, et al.
Publicado: (2022)

Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study
por: Ladenheim, Maya R, et al.
Publicado: (2016)

County-Level Variation in Cirrhosis-Related Mortality in the US, 1999-2019
por: Ha, Audrey Y., et al.
Publicado: (2022)

Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score
por: Thrift, Aaron P., et al.
Publicado: (2023)

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa
por: Mendy, M E, et al.
Publicado: (2010)

Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis
por: Shi, Ke, et al.
Publicado: (2023)

Non-hispanic whites have higher risk for pulmonary impairment from pulmonary tuberculosis
por: Pasipanodya, Jotam G, et al.
Publicado: (2012)

Comparison of Hepatocellular Carcinoma in Hispanic and Non-Hispanic Patients
por: Asemota, Joseph, et al.
Publicado: (2021)

Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma
por: Chen, Vincent L., et al.
Publicado: (2020)

Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis
por: Li, Xu, et al.
Publicado: (2019)

Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic
por: Yeo, Yee Hui, et al.
Publicado: (2023)

Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000–2015
por: Liu, Anne, et al.
Publicado: (2018)

Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics
por: Jiao, Jingjing, et al.
Publicado: (2021)

Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients
por: Hsu, Ching-Sheng, et al.
Publicado: (2013)

Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals
por: Shi, Ke, et al.
Publicado: (2023)

Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
por: Teng, Pai-Chi, et al.
Publicado: (2023)

Recognizing skin conditions in patients with cirrhosis: a narrative review
por: Liu, Ying, et al.
Publicado: (2022)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B
por: Huang, Daniel Q., et al.
Publicado: (2023)

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis
por: Park, Haesuk, et al.
Publicado: (2018)

Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
por: Shin, Sangdeok, et al.
Publicado: (2020)

Correction: Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis
por: Park, Haesuk, et al.
Publicado: (2018)

The impact of cardiovascular risk factors on cognition in Hispanics and non-Hispanic whites
por: Stickel, Ariana, et al.
Publicado: (2019)

Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California
por: Toy, Mehlika, et al.
Publicado: (2018)

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease
por: Chang, Christine Y., et al.
Publicado: (2017)

One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment
por: Tseng, Tai-Chung, et al.
Publicado: (2021)

Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma
por: Estevez, Jacqueline, et al.
Publicado: (2017)

Predictability of Liver-Related Seromarkers for the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients
por: Lin, Yu-Ju, et al.
Publicado: (2013)

On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B
por: Yang, Zeyuan, et al.
Publicado: (2023)

Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents
por: Jin, Ran, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_feuc189dui627vn6mirpltjlot